Nootropics: Reviews Reveal Undeniable Results on Neuro

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nootropics: Reviews Reveal Undeniable Results on Neuro Laboratories' Brain Enhancement Pill

NEW YORK, N.Y., June 29, 2014 (GLOBE NEWSWIRE) -- via PRWEB - There's very few people who haven't seen, or at least heard of Bradley Cooper's 2011 box office hit, Limitless – a movie featuring a little clear pill that allowed the use of 100% of the brain. This year, an upcoming movie Lucy hopes to up the stakes even further with a drug that allows the brain telekinetic powers and the ability to slow down time. What most people don't know is, that while we might still be a long way off from the Limitless pill, there are supplements available out there claiming to enhance the way your brain functions.

This is what Martin Brison and his team of enthusiasts do on a regular basis at Brain Pill Reviews, a non-profit organization set out with one purpose: finding the best available brain enhancing supplements, better known as nootropics, to optimize the overall performance we get from our brains, and according to Editor Brison, they just might have found it.

The Brain Pill Reviews team have reviewed and tested countless different nootropics from many different pharmaceutical companies, and while doing so have noticed a growing trend – the increasing effectiveness of supplements that positively affect the many key cognitive processes within the brain. Brison said "Brain pills are at the epitome of their advancement, and it seems as if pharmaceutical supplement companies have become the first to crack the code."

Brain enhancement isn't new, though. The use of nootropics began as early as 1964, when piracetam was first discovered to improve memory. However, since its first use, modern neuroscience and technology has allowed more possibilities than we could even dream of. Ginkgo Biloba itself, a plant extract used to enhance memory, has been one of America's top selling supplements for a long time. For half a decade, our newfound understanding of the brain has ushered forth the development of modern brain enhancers and nootropics that far surpass what was available many years ago.

One such modern nootropic that Brison mentioned was the critically acclaimed NITROvit from Neuro Laboratories. NITROvit, dubbed as the Advanced Cognitive Nootropic, has received a particularly positive reception on Brain Pill Reviews, as well as on many other review sites out there, nootropic forums, and, most importantly, through user feedback and testimonials. According to Editor Brison, it may very well be the closest we can get to the Limitless Pill at the moment, and will possibly hold on to that title for years to come.

NITROvit – the pride and joy behind Neuro Laboratories' success – was purportedly created as the solution to a demand for increased mental performance. Neuro Laboratories' push forward for innovation in neurological research and modern medicine has been remarkable in the past few years, which has allowed them to produce a nootropic supplement that can optimize focus, clarity, and learning capabilities – while also limiting the effects of Attention Deficit Disorder (ADD/ADHD). Neuro Laboratories' website characterizes ADD/ADHD as difficulty paying attention, maintaining focus on tasks, and controlling impulsive behaviors.

In a marketplace that is incredibly saturated, it seems as if an up-and-coming product will have difficulties competing, but Editor Martin Brison sheds light on why they've given it their Editor's Choice as one of the very best nootropics . "In an industry where there are new brain pills popping out of nowhere almost every other day, our jobs as reviewers require us to remain objective and focused on the results. When compared to the many other brain enhancers that we've reviewed, we've observed that what makes NITROvit so effective rests within its formula – each ingredient has been specifically selected to complement each other's effects, and at the right doses. Also, since there is no filler present (multivitamins, caffeine, and other proprietary ingredients), there is nothing that may take away from its overall brain enhancement potential – the result is a very potent nootropic. Consider it proper nutrition for the brain, optimizing it for increased memory, focus, concentration, and motivation."

When asked to comment on the use of brain enhancement in a professional setting, Brison explained, "While there are still some people wary of the use of these "smart drugs", we have to admit that with the current state of the global workforce market, there is a growing demand for individuals who can perform at their very best. We're seeing this every day with the growing competitiveness in work and academic environments. Everyone just wants to be that much better. And while at the moment, brain enhancement might simply be a novelty, a decade from now, it might just become necessity."

Check out NITROvit and Neuro Laboratories' upcoming products, and their solution to Brain Enhancement .

Those interested in reading Brison's full review on NITROvit, as well as countless other reviewed brain enhancers and nootropics may visit their official website, Brain Pill Reviews .

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/nootropics/brai...980907.htm

Brain Pill Reviews Martin Brison +1 (914) 587-7771

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Cryptocurrency Market Analysis: Bitcoin Hits New Low

Updated Category News Views 197

Cryptocurrency Market Update On Friday morning, cryptocurrency enthusiasts awoke to disappointing news: Bitcoin has fallen below $109,000, marking a significant decline for the leading digital asset. This marks the first time Bitcoin has dipped below this level since early September, raising questions about the current state and future of digital currencies. Key...

Continue Reading
Hagar hf. Expands Operations with P/F SMS Acquisition

Updated Category News Views 239

Hagar hf. Expands Its Business Footprint Recently, a significant announcement was made about Hagar hf. enhancing its business strategy through the acquisition of P/F SMS, a prominent supermarket chain in the Faroe Islands. This strategic move was publicized on a notable occasion, indicating the completion of a conditional agreement that allows Hagar hf. to fully acquire...

Continue Reading
Santander Achieves Impressive 12% Net Profit Growth in Q3

Updated Category News Views 238

Santander's Robust Net Profit Growth in Q3 Spain's Santander has announced an impressive 12% increase in net profit for the third quarter of 2023, underscoring the effectiveness of its retail operations. This remarkable performance has positioned the bank as one of the strongest contenders in the euro zone banking sector. Financial Highlights for Q3 In the latest...

Continue Reading
DBM Global Secures $220 Million Credit Facility for Growth

Updated Category News Views 318

DBM Global Inc. Enters Amended Credit Facility Agreement DBM Global Inc. (OTC Markets: DBMG) has recently made headlines by securing an amended and restated credit agreement that amounts to a significant total of $220 million. This financial maneuver comprises an $85 million term loan alongside a $135 million revolving credit facility, which aims to address existing debt...

Continue Reading
Projected Growth of Industrial Safety Market to USD 12.39 Billion

Updated Category News Views 82

Overview of the Industrial Safety Market Growth The Industrial Safety Market is experiencing remarkable growth, expected to expand from USD 6.74 billion in 2023 to a substantial USD 12.39 billion by 2032. This notable surge is attributed to a compound annual growth rate (CAGR) of 7%, reflecting an increased emphasis on safety within various industrial sectors. Key Factors...

Continue Reading